These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35891320)

  • 1. Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China.
    Li J; Lu J; Wang G; Zhao A; Xu M
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albert Calmette (1863-1933) and Camille Guérin (1872-1961): the C and G of BCG vaccine.
    Hawgood BJ
    J Med Biogr; 2007 Aug; 15(3):139-46. PubMed ID: 17641786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current challenges and opportunities for bacillus Calmette-Guérin replacement vaccine candidates.
    Méndez-Samperio P
    Scand J Immunol; 2019 Oct; 90(4):e12772. PubMed ID: 31055842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights of the 3rd international BCG symposium: 100th anniversary of the first administration of BCG.
    Locht C
    Microbes Infect; 2022; 24(8):105043. PubMed ID: 36084845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Human Vaccine,
    Palmer MV; Thacker TC
    Front Vet Sci; 2018; 5():244. PubMed ID: 30349823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against
    Moliva JI; Turner J; Torrelles JB
    Front Immunol; 2017; 8():407. PubMed ID: 28424703
    [No Abstract]   [Full Text] [Related]  

  • 10. The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.
    Pedroza-Roldán C; Guapillo C; Barrios-Payán J; Mata-Espinosa D; Aceves-Sánchez Mde J; Marquina-Castillo B; Hernández-Pando R; Flores-Valdez MA
    Vaccine; 2016 Sep; 34(40):4763-70. PubMed ID: 27546876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis vaccines: beyond bacille Calmette-Guerin.
    McShane H
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2782-9. PubMed ID: 21893541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacille Calmette-Guérin (BCG). Léon Charles Albert Calmette 1863-1933 Jean-Marie Camille Guérin 1872-1961.
    Birth CA
    Practitioner; 1974 Mar; 212(1269):391-2. PubMed ID: 4614251
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study.
    Liao Q; Zheng Y; Wang Y; Ye L; Liu X; Jiao W; Liu Y; Zhu Y; Jia J; Sun L; Shen A; Wan C
    Int J Infect Dis; 2022 Aug; 121():113-119. PubMed ID: 35429637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 100 years of Mycobacterium bovis bacille Calmette-Guérin.
    Lange C; Aaby P; Behr MA; Donald PR; Kaufmann SHE; Netea MG; Mandalakas AM
    Lancet Infect Dis; 2022 Jan; 22(1):e2-e12. PubMed ID: 34506734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015.
    Wansaula Z; Wortham JM; Mindra G; Haddad MB; Salinas JL; Ashkin D; Morris SB; Grant GB; Ghosh S; Langer AJ
    Emerg Infect Dis; 2019 Mar; 25(3):451-456. PubMed ID: 30789145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin vaccine related lymphadenitis in children: Management guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS).
    Elsidig N; Alshahrani D; Alshehri M; Alzahrani M; Alhajjar S; Aljummah S; Bin Hussain I; Alshaalan M; Alzamil F; Alodyani A; Aljobair F
    Int J Pediatr Adolesc Med; 2015 Jun; 2(2):89-95. PubMed ID: 30805444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis vaccine development: from classic to clinical candidates.
    Li J; Zhao A; Tang J; Wang G; Shi Y; Zhan L; Qin C
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1405-1425. PubMed ID: 32060754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
    Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
    BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.